The murine class B, type I scavenger receptor mSR-BI, a high density lipoprotein (HDL) receptor that mediates selective uptake of HDL lipids, contains 11 potential N-linked glycosylation sites and unknown numbers of both endoglycosidase H-sensitive and -resistant oligosaccharides. We have examined the consequences of mutating each of these sites (Asn 3 Gln or Thr 3 Ala) on post-translational processing of mSR-BI, cell surface expression, and HDL binding and lipid transport activities. All 11 sites were glycosylated; however, disruption of only two (Asn-108 and Asn-173) substantially altered expression and function. There was very little detectable post-translational processing of these two mutants to endoglycosidase H resistance and very low cell surface expression, suggesting that oligosaccharide modification at these sites apparently plays an important role in endoplasmic reticulum folding and/or intracellular transport. Strikingly, although the low levels of the 108 and 173 mutants that were expressed on the cell surface exhibited a marked reduction in their ability to transfer lipids from HDL to cells, they nevertheless bound nearly normal amounts of HDL. Indeed, the affinity of 125 I-HDL binding to the 173 mutant was similar to that of the wild-type receptor. Thus, N-linked glycosylation can influence both the intracellular transport and lipid-transporter activity of SR-BI. The ability to uncouple the HDL binding and lipid transport activities of mSR-BI by in vitro mutagenesis should provide a powerful tool for further analysis of the mechanism of SR-BI-mediated selective lipid uptake.
Scavenger receptor class B, type I, SR-BI,1 is a 509-residue, ϳ82-kDa integral membrane cell surface glycoprotein of the CD36 superfamily that was the first high density lipoprotein (HDL) receptor to be characterized in detail (1, 2). SR-BI helps control the structure and metabolism of HDL by mediating the transport of lipids from HDL to cells. The mechanism by which SR-BI mediates this lipid transport differs from the classic LDL receptor pathway of endocytosis, in which the entire lipoprotein is internalized via coated pits and subsequently hydrolyzed by lysosomal enzymes (3). Instead, HDL binds to SR-BI, lipids of HDL (primarily neutral lipids such as cholesteryl esters in the core of the particle) are transported into the cells, and the lipid-depleted particle is released into the extracellular space (1, 2, 4, 5). This mechanism is called selective lipid uptake (2, 4, 5). Numerous studies indicate that SR-BI-mediated selective lipid uptake is a two-step process involving productive binding of HDL (1, 6, 7) followed by bindingdependent lipid transfer. In addition to mediating selective lipid uptake, SR-BI can mediate cholesterol efflux from cells to HDL (8) via a binding-dependent process (6, 7, 9) (however see In vivo analyses of the function of SR-BI, primarily using SR-BI homozygous null mice (11, 12) and murine hepatic overexpression of SR-BI transgenes (13-18), have shown that SR-BI can profoundly influence several ph...